Eli Lilly, Novo Nordisk file competing new weight-loss drugs with the FDA that could be game changers in obesity medicine
Here's how the next generation of obesity drugs getting closer to patients differs from Wegovy and Zepbound
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
L1 Capital, an investment management firm, released its "L1 Capital International Fund" (unhedged) fourth-quarter 2025 investor letter. A copy of the lette...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesHere's how the next generation of obesity drugs getting closer to patients differs from Wegovy and Zepbound
The iShares Core S&P Total U.S. Stock Market ETF (NYSE:ITOT) returned 16.4% through mid-December, tracking the broad U.S. equity marketâEUR(TM)s strong 202...
BP's next CEO Meg O'Neill to make history as first woman to lead an oil major
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Stock Market Today: The Dow Jones index rose Thursday on a surprise CPI inflation report. Nvidia stock and Tesla rallied.
U.S. stocks surge higher on cooling inflation; more Fed cuts on the way?
Stocks jumped following the latest reading on consumer inflation that could help set expectations for the path of interest rates.
Pyxis Oncology stock plummets after early-stage cancer drug data
Eli Lilly and Novo Nordisk file their new weight-loss drugs with the FDA.
Austria's top court rules Meta's ad model illegal, orders overhaul of user data practices in EU
Tilray and Canopy Growth shares are among big gainers Thursday.
Athira Pharma stock soars after acquiring rights to Phase 3 breast cancer drug